Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 9
2005 8
2006 9
2007 11
2008 17
2009 11
2010 10
2011 20
2012 19
2013 28
2014 22
2015 21
2016 24
2017 20
2018 24
2019 21
2020 16
2021 21
2022 26
2023 23

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Results by year

Filters applied: . Clear all
Page 1
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E, Dore GJ; SIMPLIFY Study Group. Grebely J, et al. Among authors: cooper c. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6. Lancet Gastroenterol Hepatol. 2018. PMID: 29310928 Free article. Clinical Trial.
Le domaine des co-infections et des maladies concomitantes du Réseau canadien pour les essais VIH des IRSC : lignes directrices canadiennes pour la prise en charge et le traitement de la co-infection par le VIH et l'hépatite C chez les adultes.
Hull M, Giguère P, Klein M, Shafran S, Tseng A, Côté P, Poliquin M, Cooper C. Hull M, et al. Among authors: cooper c. Can J Infect Dis Med Microbiol. 2014 Spring;25(1):39-62. doi: 10.1155/2014/921314. Can J Infect Dis Med Microbiol. 2014. PMID: 24634688 Free PMC article. French.
Remaining clinical issues in hepatitis C treatment.
Wong A, Tsien C, Mansour S, Cooper C. Wong A, et al. Among authors: cooper c. Can Liver J. 2018 Jul 17;1(2):66-77. doi: 10.3138/canlivj.1.2.006. eCollection 2018 Spring. Can Liver J. 2018. PMID: 35990713 Free PMC article. Review.
Inflammation and repair in viral hepatitis C.
Neuman MG, Sha K, Esguerra R, Zakhari S, Winkler RE, Hilzenrat N, Wyse J, Cooper CL, Seth D, Gorrell MD, Haber PS, McCaughan GW, Leo MA, Lieber CS, Voiculescu M, Buzatu E, Ionescu C, Dudas J, Saile B, Ramadori G. Neuman MG, et al. Among authors: cooper cl. Dig Dis Sci. 2008 Jun;53(6):1468-87. doi: 10.1007/s10620-007-0047-3. Dig Dis Sci. 2008. PMID: 17994278 Review.
COVID-19 vaccine immunogenicity in people with HIV.
Costiniuk CT, Singer J, Lee T, Langlois MA, Arnold C, Galipeau Y, Needham J, Kulic I, Jenabian MA, Burchell AN, Shamji H, Chambers C, Walmsley S, Ostrowski M, Kovacs C, Tan DHS, Harris M, Hull M, Brumme ZL, Lapointe HR, Brockman MA, Margolese S, Mandarino E, Samarani S, Vulesevic B, Lebouché B, Angel JB, Routy JP, Cooper CL, Anis AH; COVAXHIV Study Group. Costiniuk CT, et al. Among authors: cooper cl. AIDS. 2023 Jan 1;37(1):F1-F10. doi: 10.1097/QAD.0000000000003429. Epub 2022 Nov 18. AIDS. 2023. PMID: 36476452 Free PMC article.
332 results